Meet our team.

farhana_islam-01.png

Farhana Islam, MSc

PhD Candidate
Department of Pharmacology and Toxicology | University of Toronto

Farhana is a PhD Candidate at the Department of Pharmacology and Toxicology at the University of Toronto. Her research interests are in investigating multi-omic factors that contribute to and can be used for the prediction of antidepressant and antipsychotic treatment outcomes. She has expertise in statistics and R programming, with developing expertise in Python and machine learning.

Follow Farhana on ResearchGate, Google Scholar, and LinkedIn!

Farhana’s Projects

Genomics of Antipsychotic Response

Medication Plasma Levels

Selected Publications

 

Islam F, Magarbeh L, …, Müller, DJ. The Canadian Journal of Psychiatry. 2023 Oct 55.

Effects of CYP2C19 and CYP2D6 gene variants on escitalopram and aripiprazole treatment outcome and serum levels: results from the CAN-BIND 1 study

Islam F, Marshe VS, Magarbeh, …, Müller, DJ. Translational Psychiatry. 2022 Sept 06.

Pharmacogenomics of Clozapine-induced agranulocytosis: a systematic review and meta-analysis

Islam F, Hain D, Lewis D, Law R, Brown L, Tanner J-A & Müller DJ.  The Pharmacogenomics Journal. 2022 June 16.

Pharmacogenetics-guided advances in antipsychotic treatment.

Islam F, Men X, Yoshida K, Zai CC, Müller DJ. Clin Pharmacol Ther. 2021 Jun 15.